These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2068473)

  • 1. Efficacy of aztreonam in the treatment of skeletal infections due to Pseudomonas aeruginosa.
    Conrad DA; Williams RR; Couchman TL; Lentnek AL
    Rev Infect Dis; 1991; 13 Suppl 7():S634-9. PubMed ID: 2068473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aztreonam in the treatment of bone and joint infections caused by gram-negative bacilli.
    Simons WJ; Lee TJ
    Rev Infect Dis; 1985; 7 Suppl 4():S783-8. PubMed ID: 2934786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa.
    Scully BE; Neu HC
    Am J Med; 1985 Feb; 78(2):251-61. PubMed ID: 4038574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined aztreonam and gentamicin therapy for pseudomonal lower respiratory tract infections.
    Andrews R; Fasoli R; Scoggins WG; Algozzine GJ; Spann RW; Sundaresh KV; Mathers JA; Babb R; Kuppinger M; Cooper B
    Clin Ther; 1994; 16(2):236-52. PubMed ID: 8062319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of aztreonam therapy for serious infections due to gram-negative bacteria.
    McKellar PP
    Rev Infect Dis; 1985; 7 Suppl 4():S803-9. PubMed ID: 3909340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aztreonam in the treatment of severe urinary tract infections in pediatric patients.
    Rusconi F; Assael BM; Boccazzi A; Colombo R; Crossignani RM; Garlaschi L; Rancilio L
    Antimicrob Agents Chemother; 1986 Aug; 30(2):310-4. PubMed ID: 3094442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of lower respiratory tract infections due to Pseudomonas aeruginosa in patients with cystic fibrosis.
    Scully BE; Ores CN; Prince AS; Neu HC
    Rev Infect Dis; 1985; 7 Suppl 4():S669-74. PubMed ID: 3909322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Pseudomonas aeruginosa osteomyelitis with aztreonam.
    Smith DW; Wilson RD
    Med J Aust; 1987 Aug; 147(3):152. PubMed ID: 3600480
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety of aztreonam in patients with cystic fibrosis and allergy to beta-lactam antibiotics.
    Jensen T; Pedersen SS; Høiby N; Koch C
    Rev Infect Dis; 1991; 13 Suppl 7():S594-7. PubMed ID: 2068465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overall clinical experience with aztreonam in the treatment of intraabdominal infections.
    Henry SA
    Rev Infect Dis; 1985; 7 Suppl 4():S729-33. PubMed ID: 3909331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of aztreonam in the treatment of patients with renal failure.
    Sion ML; Pyrpasopoulos M; Nicolaidis P; Papagianni C; Tsurutsoglu G
    Rev Infect Dis; 1991; 13 Suppl 7():S652-4. PubMed ID: 2068477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aztreonam therapy for experimental osteomyelitis caused by Pseudomonas aeruginosa.
    Norden CW; Budinsky A
    J Infect Dis; 1988 Sep; 158(3):660-1. PubMed ID: 3411154
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of aztreonam in the treatment of severe bacterial infections.
    Romero-Vivas J; Rodríguez-Créixems M; Bouza E; Hellín T; Guerrero A; Martínez-Beltrán J; García de la Torre M
    Antimicrob Agents Chemother; 1985 Aug; 28(2):222-6. PubMed ID: 3834832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteomyelitis and septic arthritis in premature infant.
    Goldstein B; Manolas P; Silver JW
    Orthop Rev; 1987 Jul; 16(7):476-9. PubMed ID: 3453981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Summary of worldwide clinical trials of aztreonam in patients with urinary tract infections.
    Swabb EA; Jenkins SA; Muir JG
    Rev Infect Dis; 1985; 7 Suppl 4():S772-7. PubMed ID: 3909336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of aztreonam in association with cefepime for the treatment of nosocomial infections due to multidrug-resistant strains of Pseudomonas aeruginosa to β-lactams in ICU patients: A pilot study.
    Dupont H; Marciniak S; Zogheib E; Mammeri H; Friggeri A; Ammenouche N; Levrard M; Airapetian N; Tinturier F; Mahjoub Y
    Anaesth Crit Care Pain Med; 2015 Jun; 34(3):141-4. PubMed ID: 26004874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aztreonam therapy for serious gram-negative infections in children.
    Stutman HR; Chartrand SA; Tolentino T; Friedhoff L; Marks MI
    Am J Dis Child; 1986 Nov; 140(11):1147-51. PubMed ID: 3766490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of gram-negative infections with aztreonam.
    Simons WJ; Lee TJ
    Am J Med; 1985 Feb; 78(2A):27-30. PubMed ID: 4038577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aztreonam in the treatment of serious orthopedic infections.
    Pribyl C; Salzer R; Beskin J; Haddad RJ; Pollock B; Beville R; Holmes B; Mogabgab WJ
    Am J Med; 1985 Feb; 78(2A):51-6. PubMed ID: 3881949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aztreonam: worldwide overview of the treatment of patients with gram-negative infections.
    Henry SA; Bendush CB
    Am J Med; 1985 Feb; 78(2A):57-64. PubMed ID: 3881950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.